We further tested whether Mek inhibition promotes covalent binding of ErbB2 to a protein ubiquitin and subsequent ErbB2 proteasomal degradation (a known mechanism of protein turnover [37]) in detached breast cancer cells. Here, ERBB2 is linked to breast cancer.